Table 3.
Multivariate analysis
| OR | 95% CI | p value* | |
|---|---|---|---|
| a Clinical outcome mRS 90 days 0–2 vs. 3–6 (n = 363) | |||
| Group 1: IVT vs. group 2: IVT + mTE/aTE | 1.16 | 0.50–2.71 | 0.728 |
| Group 1: IVT vs. group 3: mTE/aTE | 1.34 | 0.64–2.81 | 0.439 |
| Female vs. male | 0.58 | 0.34–0.98 | 0.042 |
| DM | 0.53 | 0.29–0.99 | 0.046 |
| SAH | 0.27 | 0.10–0.71 | 0.008 |
| Age, years | 0.94 | 0.92–0.97 | <0.001 |
| NIHSS | 0.88 | 0.85–0.92 | <0.001 |
| ASPECTS | 1.32 | 1.11–1.58 | 0.002 |
| b Mortality at 90 days (n = 363) | |||
| Group 1: IVT vs. group 2: IVT + mTE/aTE | 0.95 | 0.29–3.13 | 0.931 |
| Group 1: IVT vs. group 3: mTE/aTE | 0.47 | 0.15–1.46 | 0.189 |
| Age, years | 1.07 | 1.03–1.10 | <0.001 |
| NIHSS | 1.12 | 1.07–1.17 | <0.001 |
| ASPECTS | 0.75 | 0.65–0.86 | <0.001 |
| c Complete reperfusion (n = 429) | |||
| Group 1: IVT vs. group 2: IVT + mTE/aTE | |||
| mTICI 3 vs. mTICI 0–2b | 0.15 | 0.08–0.29 | <0.001 |
| mTICI 0–2b vs. 3 | 6.67 | 3.45–12.50 | <0.001 |
| Group 1: IVT vs. group 3: mTE/aTE | |||
| mTICI 3 vs. mTICI 0–2b | 0.17 | 0.09–0.32 | <0.001 |
| mTICI 0–2b vs. 3 | 5.88 | 3.13–11.11 | <0.001 |
* Statistics: logistic regression with forward selection.
DM, diabetes mellitus; SAH, subarachnoid hemorrhage; ASPECTS, Alberta Stroke Program Early Computed Tomography Score; IVT, intravenous thrombolysis; IVT + mTE/aTE, intravenous thrombolysis and subsequently mechanical and/or aspiration thrombectomy; NIHSS, National Institute of Health Stroke Scale; mRS, modified Rankin Scale; mTE/aTE, mechanical and/or aspiration thrombectomy; mTICI, modified treatment in cerebral ischemia score.